As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: April 14, 2012
by Virtual Medical Centre
An interdisciplinary team of scientists at the University of Newcastle has shown the potential of a simple blood-based test to identify people in the early stages of Alzheimer’s disease, before any symptoms appear.
The team of four spent a year studying data from the international Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, the most comprehensive collection of Alzheimer’s data in the world.
The Newcastle team assessed the levels of 190 proteins in blood from 566 people with either Alzheimer’s Disease, mild cognitive impairment or normal cognition and showed that measuring a panel of 11 proteins in blood can provide a predictive test with more than 85 per cent accuracy. Monitoring the change in blood protein levels over time could increase accuracy above 90 per cent.
The studys findings are published in the prestigious PLoS ONE journal.
Senior author Professor Pablo Moscato said the results were likely to be significant for the way Alzheimer’s was diagnosed.
“Currently, Alzheimer’s disease diagnosis is based on clinical observations and testing of cognitive capacity and memory loss,” he said.
“The only reliable and accurate biological markers so far identified for early diagnosis require measurement by either expensive procedures such as brain imaging, or invasive procedures, for example spinal punctures.
“Our study makes a considerable step towards cheap, non-invasive testing by identifying a blood protein panel to predict Alzheimer’s disease in its early stages.”
Early detection of Alzheimer’s disease is considered vital for effective intervention as there is no cure. The only available treatments are drugs that improve the functioning of neurons but do not stop the disease progressing.
Alzheimer’s disease attacks the brain resulting in impaired memory, thinking and behaviour. It is the most common form of dementia, affecting one in 25 Australians aged 60 years and over.
Antihypertensive therapy to lower elevated blood pressure (BP) decreases the risk for dementia and Alzheimer’s disease (AD) in older adults, and the benefits may be gained by several different drug classes, new research shows. Debate...
The Alzheimer’s Association estimated the direct cost to American society of Alzheimer’s and other dementias to be $259 billion in 2017. Because of the increasing number of older individuals being diagnosed, there is an ever-increasing need for ways to treat and lower risk of dementia. A...
It’s pretty extraordinary for people in their 80s and 90s to keep the same sharp memory as someone several decades younger, and now scientists are peeking into the brains of these “superagers” to uncover...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.